for each of the 5 SNVs(passive) was designedOne assay
to capture DNA translocations in diseases such as Ewing sarcoma , primarily concentrating on regions of the genome where these translocations are likely to occur(passive) was designedOne assay
to simultaneously quantify the levels of multiple phosphorylated proteins ( see figure(passive) is designed3-Plex assay
to identify immunoglobulin ( IgA , IgE , IgG and IgM ) secreting B cells(passive) is designedFluroSpot assay
to identify genetic variants of the MTHFR gene(passive) is designedMTHFR Assay
to detect and study activated AKT directly in whole cells(passive) is designedSer473 ) assay
to detect individual DNA sequences associated with cancer(passive) is designedclonoSEQ Assay
to identify CFTR genetic variants(passive) is designedCFTR-31 Assay
the viruscausingCOVID-19. Assay
in order to test the viability of the application(passive) is designed/ Cas9 assay
for simultaneous detection of 139 clinically relevant disease - causing mutations and variants within the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene(passive) is designed139-Variant Assay
to be used for ( a(passive) is designedAssay Diluent
so that the observed activity is proportional to the amount of enzyme present in order that the enzyme concentration is the only limiting factor(passive) must be designedassay
the Primer Express software(passive) were designed bynuclease assay
to measure creatinine levels in plasma and serum(passive) is designedAssay
to identify select genetic variants of MDR1(passive) is designedMDR1 Assay
to identify genetic variants for ApoE and report the isoform(passive) is designedApoE assay
to detect these changes at the genomic level(passive) was designedassay
to reduce sample matrix effects(passive) are designedAssay diluents
to bind with these cell - free DNA fragments(passive) is designedassay
to detect mutations in the ApoE gene(passive) is designedAssay
for use with human urine(passive) is designedassay
for use with human urine only(passive) is designedassay
as a platform for high - throughput screening ( HTS(passive) was designedassay
to genotype this polymorphism by primer extension with analyte detection on a MALDI - TOF mass spectrometer using a pair of internal primers(passive) was designedAn assay
use of Primer Express software(passive) was designed byassay
for simultaneous detection of 139 clinically relevant disease - causing mutations and variants within the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene(passive) is designedAssay
No . 6 Sample number Sampling positionresultsAssay
for qualitative determination of drug substances in human urine specimens(passive) is designedassay
a positive anti - drug antibodyresultassay
Sample number Sampling positionresultsAssay
to detect(passive) is designedassay
of negative controls , positive controls , and test samples(passive) was composedAssay
A pH lower than 2can causeassay
with the most up - to - data sequence information(passive) has been designedAssay
for qualitative detection of ribosomal RNA of the(passive) is designedassay
for qualitative detection of ribosomal RNA(passive) is designedassay
to probe metabolic stability and measure kinetic stability(passive) 's designedassay
in order to test the viability of the application(passive) is designedassay
to detect the presence of the BRAF V600E mutation in formalin - fixed , paraffin - embedded ( FFPE ) melanoma tissuedesignedto detect the presence of the BRAF V600E mutation in formalin - fixed , paraffin - embedded ( FFPE ) melanoma tissue
for the detection and quantification of the allergendesignedfor the detection and quantification of the allergen
The primers of four Tag SNPs(passive) were designed byThe primers of four Tag SNPs
A diagram of the approach used to evaluate urinary cells(passive) is designedA diagram of the approach used to evaluate urinary cells
for comprehensive genomic profiling of cancers affecting children and young adultsdesignedfor comprehensive genomic profiling of cancers affecting children and young adults
for measuring events from monolayers of cellsoriginally designedfor measuring events from monolayers of cells
for humans for detection of antineutrophil cytoplasmic antibodies in dogs with chronic enteropathiesdesignedfor humans for detection of antineutrophil cytoplasmic antibodies in dogs with chronic enteropathies
to an increase in release of LDHleadingto an increase in release of LDH
for detection and analysis of known and emerging solid tumor biomarkersdesignedfor detection and analysis of known and emerging solid tumor biomarkers
for diabetes diagnosis and has been reviewed by the FDAwas designedfor diabetes diagnosis and has been reviewed by the FDA
to test for inhibition of the detection method using 50 mMdesignedto test for inhibition of the detection method using 50 mM
for qualitative detection of multiple drugs and drug metabolites in human salivadesignedfor qualitative detection of multiple drugs and drug metabolites in human saliva
to detect common resistance - associated mutationsdesignedto detect common resistance - associated mutations
with specific rabbit polyclonal antibodies for coating the ELISA plate and preparation of Horse Radish Peroxidase ( HRP ) markerdesignedwith specific rabbit polyclonal antibodies for coating the ELISA plate and preparation of Horse Radish Peroxidase ( HRP ) marker
for the amplification of low DNA template samplesdesignedfor the amplification of low DNA template samples
for the direct detection of bacterial species in EDTA human whole blooddesignedfor the direct detection of bacterial species in EDTA human whole blood
for 14 of the holes have been completed in full , while assay results for 5 of the holes have been partially completed , and assays for an additional 5 holes are pending in fullresultsfor 14 of the holes have been completed in full , while assay results for 5 of the holes have been partially completed , and assays for an additional 5 holes are pending in full
high levels of profilin-1 proteindiscoveredhigh levels of profilin-1 protein
The assay results reported within this releaseresultsThe assay results reported within this release
with specific rabbit polyclonal antibodiesdesignedwith specific rabbit polyclonal antibodies
for samples from drill holesresultsfor samples from drill holes
for samples from three other holesresultsfor samples from three other holes
for qualitative detection of human chorionic gonadotropin ( hCG ) in human urinedesignedfor qualitative detection of human chorionic gonadotropin ( hCG ) in human urine
with affinity purified rabbit polyclonal antibodies for coating the ELISA plate and preparation of Horse Radish Peroxidase ( HRP ) markerdesignedwith affinity purified rabbit polyclonal antibodies for coating the ELISA plate and preparation of Horse Radish Peroxidase ( HRP ) marker
with affinity purified rabbit polyclonal antibodies for coating the ELISA plate and preparation of Horse Radish Peroxidase ( HRP ) marker designedwith affinity purified rabbit polyclonal antibodies for coating the ELISA plate and preparation of Horse Radish Peroxidase ( HRP ) marker
for all three drill holesresultsfor all three drill holes
from three drill holesresultsfrom three drill holes
a loss of sensitivity and inaccurate quantificationthus causinga loss of sensitivity and inaccurate quantification
with two Murine monoclonal antibodies , the first one highly specific for human DDimerdesignedwith two Murine monoclonal antibodies , the first one highly specific for human DDimer
for these two drill holesresultsfor these two drill holes
for rapid detection of somatic mutations across the hotspot regions of 65 oncogenes and tumor suppressor genesdesignedfor rapid detection of somatic mutations across the hotspot regions of 65 oncogenes and tumor suppressor genes
for samples from nine ( 9 ) drill holesresultsfor samples from nine ( 9 ) drill holes
for four diamond drill holesresultsfor four diamond drill holes
from four of these drill holesresultsfrom four of these drill holes
from four more drill holesresultsfrom four more drill holes
A primer or probe useful for detecting a SNP in an allele specific PCR assay or a ligase chain reaction(passive) is designedA primer or probe useful for detecting a SNP in an allele specific PCR assay or a ligase chain reaction
This new HIV high - throughput screening ( HTS(passive) is designedThis new HIV high - throughput screening ( HTS
for the qualitative determination of human chorionicdesignedfor the qualitative determination of human chorionic
for allele - specific PCRdesignedfor allele - specific PCR